Electrical storm is defined by at least three episodes of sustained ventricular tachyarrhythmias or appropriate shocks given by implantable cardiac defibrillator devices (ICD), occurring within a period of 24 hours. In the present manuscript, we present the case of a 69-year-old female patient with previous aortocoronary bypass, who was admitted from the Emergency Department after presenting several episodes of syncope in prehospital settings and presented 4 episodes of sustained ventricular tachycardia which required electrical cardioversion. The arrhythmia disappeared after percutaneous revascularization of a chronic occlusion in the right coronary artery. In this case, the implantation of an ICD was avoided, as a reversible cause of ES has been identified and treated.
INTRODuCTION
The expression "electrical storm" (ES) was first described in the 1990's, to indicate a scenario of electrical instability due to repeated ventricular arrhythmias in a short period of time. This entity was associated with a high mortality rate, requiring urgent therapeutic interventions, intensive cardiovascular care, multiple electrical cardioversions, and hemodynamic support. 1, 2 The presence of more than three sustained episodes of ventricular tachyarrhythmias, or appropriate shocks given by implantable cardiac defibrillator devices (ICD) occurring during a period of 24 hours is the current accepted definition of ES. 3 Sustained ventricular arrhythmias include sustained ventricular tachycardia (lasting more than 30 seconds, with subsequent hemodynamic impairment or requiring therapeutic intervention for termination), and ventricular fibrillation. 4 Sudden cardiac death (SCD), as a possible consequence of ES, is accountable for more than half of the total cardiovascular deaths, from which 25% represent the first manifestation of an asymptomatic, silent underlying cardiovascular disorder. 5, 6 Out-of-hospital cardiac arrest is linked to a still low survival rate of 10%, being even lower in cases occurring at the patient's home (6% survival rate), compared to cardiac arrest occurring in public places, when the association of by-stander resuscitation, the use of automatic external defibrillators, and early arrival of first responders can lead to an increase in survival rates. 7 On the other hand, in-hospital cardiac arrest has a survival rate as high as 24%, depending on the underlying cause and the availability of intensive care and advanced life support.
3,7
ES is associated with increased mortality rates, albeit the exact number is still unknown. Being a life-threatening condition, it requires emergency hospitalization.
The MADIT II (Multicenter Automatic Defibrillator Implantation Trial) study, conducted on 719 patients with ICD, out of which 4% (n = 27) presented ES, revealed that there was a 17.8-fold increase in the 3-month death rate (95% CI 8-39.6, p <0.01) for subjects that presented ES compared to those with no arrhythmic events. This risk was maintained even after 3 months (HR for death 3.5, 95% CI 1.2-9.8, p = 0.02). 8 The clinical presentation of ES includes a variety of symptoms that can range from lack of any symptoms to syncope or pre-syncopal states.
In some cases, it can lead to cardiogenic shock in subjects with repeated episodes of ventricular arrhythmias associated with hemodynamic impairment and requiring critical cardiac care. 9 The presence of ES in patients with non-ischemic cardiomyopathy is also associated with increased mortality rates, as well as with higher rates of patients requiring heart transplantation (up to 54%). 
CASE PRESENTATION
A 69-year-old female patient, with a history of coronary artery disease and heart failure (HF), presented to the Emergency Department of a secondary care hospital after 
12-h period).
After electrical stabilization, the patient was referred to a tertiary care hospital, in a PCI center, for further investigations and treatment. During transportation, the patient presented 3 other episodes of self-limiting ventricular tachycardia, for which no electrical cardioversion was required.
Upon admission in the tertiary care unit, the patient was stable and asymptomatic, and the ECG tracing revealed sinus rhythm with left bundle branch block, ventricular extrasystole with "R-on-T" phenomenon, and a prolonged corrected QT interval (550 milliseconds) (Figure 1) . Laboratory revealed no electrolyte imbalance, but there were increased levels of troponin I (11.1 ng/mL) and creatine-kinase MB (329 ng/mL). After revascularization, the patient did not present any other episode of electrical instability, and no repeated sustained or non-sustained ventricular tachycardias were recorded.
The patient was discharged 3 days after revascularization, on dual antiplatelet therapy, oral anticoagulation, ACE inhibitors, diuretics, and beta blockers.
DISCuSSIONS
The present case was a female patient with ES present- The most frequent cause of sustained ventricular tachyarrhythmias is the presence of structural heart disease, which triggers re-entry mechanisms around the fibrotic area within the myocardium. Myocardial fibrosis occurs as a structural modification in ischemic and non-ischemic cardiomyopathies, after AMI with subsequent LV remodeling. 13 Other triggers include electrolyte disturbances, worsening HF, and even psychological stress due to adrenergic activation. Risk factors for ES include a severely impaired LV function, end-stage renal disease, or the presence of initial ventricular tachycardia as associated with the development of ESs. 14 The presented case was a patient with ischemic dilated cardiomyopathy, occurring after a previ- In the presented case, the patient did not present any other episodes of ventricular tachyarrhythmias after revascularization, which suggests that the cause of ES was the myocardial ischemia in the territory supplied by the RCA. Furthermore, the patient did not benefit from intracardiac defibrillator, which was not indicated as there was a correctable cause for the electrical storm.
Implantation of an ICD is contraindicated in the acute phase of ES, but the current therapeutic guidelines recommend device therapy for the secondary prevention of SCD in patients who had suffered an ES, with untreatable structural cardiac disease, after the exclusion of correctable causes such as acute coronary syndromes or dyselectrolitemia.
3 FIGuRE 4. Angiography of the right coronary artery showing 60% aorto-ostial stenosis, followed by occlusion in the vertical segment 
